Adverse events315

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 315

Type	Event	Organ system	Group	Affected	At risk
other	Diarrhoea (Excl Infective)	Gastrointestinal disorders	Febuxostat 80 mg QD	38	801
other	Diarrhoea (Excl Infective)	Gastrointestinal disorders	Febuxostat 120 mg QD	33	487
other	Diarrhoea (Excl Infective)	Gastrointestinal disorders	Allopurinol QD	4	178
other	Oedema NEC	General disorders	Febuxostat 80 mg QD	49	801
other	Oedema NEC	General disorders	Febuxostat 120 mg QD	17	487
other	Oedema NEC	General disorders	Allopurinol QD	3	178
other	Influenza Viral Infections	Infections and infestations	Febuxostat 80 mg QD	44	801
other	Influenza Viral Infections	Infections and infestations	Febuxostat 120 mg QD	16	487
other	Influenza Viral Infections	Infections and infestations	Allopurinol QD	2	178
other	Lower Respiratory Tract and Lung Infections	Infections and infestations	Febuxostat 80 mg QD	60	801
other	Lower Respiratory Tract and Lung Infections	Infections and infestations	Febuxostat 120 mg QD	27	487
other	Lower Respiratory Tract and Lung Infections	Infections and infestations	Allopurinol QD	6	178
other	Upper Respiratory Tract Infections	Infections and infestations	Febuxostat 80 mg QD	246	801
other	Upper Respiratory Tract Infections	Infections and infestations	Febuxostat 120 mg QD	119	487
other	Upper Respiratory Tract Infections	Infections and infestations	Allopurinol QD	30	178
other	Joint Related Signs and Symptoms	Musculoskeletal and connective tissue disorders	Febuxostat 80 mg QD	100	801
other	Joint Related Signs and Symptoms	Musculoskeletal and connective tissue disorders	Febuxostat 120 mg QD	50	487
other	Joint Related Signs and Symptoms	Musculoskeletal and connective tissue disorders	Allopurinol QD	12	178
other	Musculoskeletal and Connective Tissues Signs and Symptoms NEC	Musculoskeletal and connective tissue disorders	Febuxostat 80 mg QD	140	801
other	Musculoskeletal and Connective Tissues Signs and Symptoms NEC	Musculoskeletal and connective tissue disorders	Febuxostat 120 mg QD	82	487

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00175019/events

API reference For AI assistants

Adverse events315

Sources 3

Read this list from software.